These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
528 related articles for article (PubMed ID: 17536877)
1. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase. Edwards IR; Star K; Kiuru A Drug Saf; 2007; 30(6):515-25. PubMed ID: 17536877 [TBL] [Abstract][Full Text] [Related]
2. Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study. Golomb BA; Kwon EK; Koperski S; Evans MA Drug Saf; 2009; 32(8):649-61. PubMed ID: 19591530 [TBL] [Abstract][Full Text] [Related]
3. Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System. Golomb BA; Verden A; Messner AK; Koslik HJ; Hoffman KB Drug Saf; 2018 Apr; 41(4):403-413. PubMed ID: 29427042 [TBL] [Abstract][Full Text] [Related]
4. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system. Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724 [TBL] [Abstract][Full Text] [Related]
5. Statins and amyotrophic lateral sclerosis--the level of evidence for an association. Sørensen HT; Lash TL J Intern Med; 2009 Dec; 266(6):520-6. PubMed ID: 19930099 [TBL] [Abstract][Full Text] [Related]
6. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports. Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302 [TBL] [Abstract][Full Text] [Related]
7. Association between statin use and lupus-like syndrome using spontaneous reports. de Jong HJ; Tervaert JW; Saldi SR; Vandebriel RJ; Souverein PC; Meyboom RH; van Loveren H; Klungel OH Semin Arthritis Rheum; 2011 Dec; 41(3):373-81. PubMed ID: 21868063 [TBL] [Abstract][Full Text] [Related]
8. Statin-associated immune-mediated necrotizing myopathy: a retrospective analysis of individual case safety reports from VigiBase. Essers D; Schäublin M; Kullak-Ublick GA; Weiler S Eur J Clin Pharmacol; 2019 Mar; 75(3):409-416. PubMed ID: 30430215 [TBL] [Abstract][Full Text] [Related]
9. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy. Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462 [TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis associated with statins. A disproportionality analysis of the WHO Program for International Drug Monitoring database (VigiBase). Macías Saint-Gerons D; Castro JL Eur J Clin Pharmacol; 2019 Apr; 75(4):587-589. PubMed ID: 30470902 [No Abstract] [Full Text] [Related]
11. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting. Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028 [TBL] [Abstract][Full Text] [Related]
12. Cataracts and statins. A disproportionality analysis using data from VigiBase. Macías Saint-Gerons D; Bosco Cortez F; Jiménez López G; Castro JL; Tabarés-Seisdedos R Regul Toxicol Pharmacol; 2019 Dec; 109():104509. PubMed ID: 31669197 [TBL] [Abstract][Full Text] [Related]
13. Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction. Strandell J; Bate A; Hägg S; Edwards IR Br J Clin Pharmacol; 2009 Sep; 68(3):427-34. PubMed ID: 19740401 [TBL] [Abstract][Full Text] [Related]
14. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? Clark DW; Strandell J Eur J Clin Pharmacol; 2006 Jun; 62(6):473-9. PubMed ID: 16758264 [TBL] [Abstract][Full Text] [Related]
15. Statin-induced myasthenia: A disproportionality analysis of the WHO's VigiBase pharmacovigilance database. Gras-Champel V; Batteux B; Masmoudi K; Liabeuf S Muscle Nerve; 2019 Oct; 60(4):382-386. PubMed ID: 31298743 [TBL] [Abstract][Full Text] [Related]
16. Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database. Boonmuang P; Nathisuwan S; Chaiyakunapruk N; Suwankesawong W; Pokhagul P; Teerawattanapong N; Supsongserm P Drug Saf; 2013 Sep; 36(9):779-87. PubMed ID: 23615756 [TBL] [Abstract][Full Text] [Related]
17. Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®. Ampadu HH; Hoekman J; de Bruin ML; Pal SN; Olsson S; Sartori D; Leufkens HG; Dodoo AN Drug Saf; 2016 Apr; 39(4):335-45. PubMed ID: 26754924 [TBL] [Abstract][Full Text] [Related]
18. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy. Chang JT; Staffa JA; Parks M; Green L Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925 [TBL] [Abstract][Full Text] [Related]
19. Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System. Gaimari A; Fusaroli M; Raschi E; Baldin E; Vignatelli L; Nonino F; De Ponti F; Mandrioli J; Poluzzi E Drug Saf; 2022 Jun; 45(6):663-673. PubMed ID: 35610460 [TBL] [Abstract][Full Text] [Related]
20. Statins and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Zheng Z; Sheng L; Shang H Amyotroph Lateral Scler Frontotemporal Degener; 2013 May; 14(4):241-5. PubMed ID: 23134508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]